rhGAA in Patients With Infantile-onset Glycogen Storage Disease-II (Pompe Disease)
NCT00053573
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Glycogen Storage Disease Type II
Pompe Disease
Acid Maltase Deficiency Disease
Glycogenosis 2
Interventions
BIOLOGICAL:
Myozyme
Sponsor
Genzyme, a Sanofi Company